METHODS FOR TREATING DISSEMINATED INTRAVASCULAR COAGULATION BY INHIBITING MASP-2 DEPENDENT COMPLEMENT ACTIVATION
    9.
    发明公开
    METHODS FOR TREATING DISSEMINATED INTRAVASCULAR COAGULATION BY INHIBITING MASP-2 DEPENDENT COMPLEMENT ACTIVATION 审中-公开
    VERFAHREN ZUR BEHANDLUNG AUSGEBREITETERINTRAVASKULÄRERGERINNUNG DURCH HEMMUNG MASP-2-ABHÄNGIGERKOMPLEMENTAKTIVIERUNG

    公开(公告)号:EP3150635A3

    公开(公告)日:2017-06-21

    申请号:EP16199359

    申请日:2010-10-15

    IPC分类号: C07K16/40

    摘要: In one aspect, the invention provides methods of inhibiting the effects of MASP-2-dependent complement activation in a living subject. In one embodiment, the invention provides methods of treating a subject suffering from a complement mediated coagulation disorder, such as disseminated intravascular coagulation. The methods comprise the step of administering, to a subject in need thereof, an amount of a MASP-2 inhibitory agent effective to inhibit MASP-2-dependent complement activation. In some embodiments, the MASP-2 inhibitory agent inhibits cellular injury associated with MASP-2-mediated alternative complement pathway activation, while leaving the classical (Clq-dependent) pathway component of the immune system intact. In another aspect, the invention provides compositions for inhibiting the effects of lectin-dependent complement activation, comprising a therapeutically effective amount of a MASP-2 inhibitory agent and a pharmaceutically acceptable carrier.

    摘要翻译: 一方面,本发明提供了抑制活体中MASP-2依赖性补体活化作用的方法。 在一个实施方案中,本发明提供了治疗患有补体介导的凝血病症(例如弥散性血管内凝血)的受试者的方法。 该方法包括向有需要的受试者施用有效抑制MASP-2依赖性补体激活的量的MASP-2抑制剂的步骤。 在一些实施方案中,MASP-2抑制剂抑制与MASP-2介导的替代补体途径活化相关的细胞损伤,同时保持免疫系统的经典(Clq依赖性)途径组分完整。 另一方面,本发明提供了用于抑制凝集素依赖性补体活化作用的组合物,其包含治疗有效量的MASP-2抑制剂和药学上可接受的载体。

    METHODS FOR TREATING DISSEMINATED INTRAVASCULAR COAGULATION BY INHIBITING MASP-2 DEPENDENT COMPLEMENT ACTIVATION
    10.
    发明公开
    METHODS FOR TREATING DISSEMINATED INTRAVASCULAR COAGULATION BY INHIBITING MASP-2 DEPENDENT COMPLEMENT ACTIVATION 审中-公开
    一种用于治疗传播性血管内凝血BY抑制MASP-2依赖的补

    公开(公告)号:EP3150635A2

    公开(公告)日:2017-04-05

    申请号:EP16199359.7

    申请日:2010-10-15

    IPC分类号: C07K16/40

    摘要: In one aspect, the invention provides methods of inhibiting the effects of MASP-2-dependent complement activation in a living subject. In one embodiment, the invention provides methods of treating a subject suffering from a complement mediated coagulation disorder, such as disseminated intravascular coagulation. The methods comprise the step of administering, to a subject in need thereof, an amount of a MASP-2 inhibitory agent effective to inhibit MASP-2-dependent complement activation. In some embodiments, the MASP-2 inhibitory agent inhibits cellular injury associated with MASP-2-mediated alternative complement pathway activation, while leaving the classical (Clq-dependent) pathway component of the immune system intact. In another aspect, the invention provides compositions for inhibiting the effects of lectin-dependent complement activation, comprising a therapeutically effective amount of a MASP-2 inhibitory agent and a pharmaceutically acceptable carrier.

    摘要翻译: 在一个方面,本发明提供的抑制在活的受试者MASP-2依赖性补体活化的影响的方法。 在一个,实施例本发明提供治疗由补体介导凝血障碍,:患有如弥散性血管内凝血的方法。 方法包括施用的步骤,以在需要其的受试者,在一个有效MASP-2抑制剂的量来抑制MASP-2依赖性补体活化。 在一些实施方案中,MASP-2抑制剂抑制与MASP-2介导的补体旁路途径活化相关的细胞损伤,同时使经典(C1q的依赖性)途径免疫系统的组成部分保持完整。 在另一个方面,本发明提供用于抑制凝集素依赖性补体激活的作用,其包含治疗有效量的MASP-2抑制剂和药学上可接受的载体的组合物。